References
- The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complication in insulin-dependent diabetes mellitus: the diabetes control and complications trial research group. N Engl J Med 1993;329:978–86.
- United Kingdom Prospective Diabetes Study (UKPDS). Intensive blood-glucose control with sulphonylureas or insuline compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53.
- Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, Lernmark A, Metzger BE, Nathan DM. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011;34:e61–99.
- World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus (abbreviated Report of a WHO Consultation), 2011. (Accessed February 2016 at http://www.who.int/diabetes/publications/report-hba1c_2011.pdf).
- Standards of medical care in diabetes – 2013. Diabetes Care 2013;36:S11–S66.
- IFCC Working Group HbA1c. Approved laboratories of the IFCC network laboratories for HbA1c. (Accessed February 2016 at: www.ifcchba1c.net/network/approved.
- NGSP Network Laboratory Members. (Accessed February 2016 at: http://www.ngsp.org/network.asp).
- HbVar. A database of human hemoglobin variants and thalassemias. (Accessed February 2016 at: http://globin.cse.psu.edu/globin/hbvar/).
- Landin B, Jeppsson JO. Rare beta chain haemoglobin variants found in Swedish patients during HbA1c analysis. Hemoglobin 1993;4:303–18.
- Lenters-Westra E, Slingerland RJ. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem 2010;56:44–52.
- Lenters-Westra E, Slingerland RJ. Three of seven hemoglobin A1c point-of-care instruments do not meet the generally accepted analytical performance criteria. Clin Chem 2014;60:1062–72.
- Little RR, Vesper H, Rohlfing CL, Ospina M, Safar-Pour S, Roberts WL. Validation by a mass spectrometric reference method of use of boronate affinity chromatography to measure glycohemoglobin in the presence of hemoglobin S and C traits. Clin Chem 2005;51:265–6.
- Little RR, Roberts WL. A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol 2009;3:446–51.
- Lin CN, Emery T, Little RR, Hanson SE, Rohlfing CL, Jaissonc S, Gillery P, Roberts WL. Effects of hemoglobin C, D, E, and S traits on measurements of HbA1c by six methods. Clin Chim Acta 2012;413:819–21.
- Little RR, La’ulu SL, Hanson SE, Rohlfing CL, Schmidt RL. Effects of 49 different rare Hb variants on HbA1c measurement in eight methods. J Diabetes Sci Technol 2015;9:849–56.
- IFCC Working Group HbA1c. IFCC Monitoring Programme. (Accessed February 2016 at: www.ifcchba1c.net).
- Little RR, Rohlfing CL, Wiedmeyer H-M, Myers GL, Sacks DB, Goldstein DE. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001;47:1985–92.
- Little RR. Glycated haemoglobin standardization. National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med 2003;41:1191–9.
- EP evaluator. (Accessed February 2016 at: https://www.datainnovations.com/products/ep-evaluator).
- NGSP HbA1c Assay Interference. (Accessed February 2016 at: http://www.ngsp.org/interf.asp).
- Bailon P, Ehrlich GK, Fung WJ, Berthold W. Affinity Chromatography Methods and Protocols (Book). (Accessed November 2015 at: https://books.google.com/books?id=7zVYOXB6VCIC&pg=PA125&lpg=PA125&dq=affinity+chromatography+secondary+ionic+interactions&source=bl&ots=XXAkLverem&sig=DcTjRaZHrqfSBZJ6QZczD18XmAs&hl=en&sa=X&ei=536-VLKuL8v3yQSAm4GoCA&ved=0CCMQ6AEwAA#v=onepage&q=affinity%20chromatography%20secondary%20ionic%20interactions&f=false).
- Abadie JM, Koelsch AA. Performance of the Roche second generation hemoglobin A1c immunoassay in the presence of Hb-S or Hb-C traits. Ann Clin Lab Sci 2008;38:31–6.